Vonoprazan Fumarate

Vonoprazan Fumarate | USP/EP-Certified Bulk API for Acid Reflux & Ulcer Treatment‌

🔬 ‌Product Overview‌

Vonoprazan Fumarate (TAK-438), a next-generation ‌potassium-competitive acid blocker (P-CAB)‌, is engineered for superior gastric acid suppression in ‌GERD (gastroesophageal reflux disease)‌ and ‌peptic ulcer therapy‌‌12. With high bioavailability and rapid action, it outperforms traditional PPIs in pH control and treatment adherence‌34.

🌟 ‌Key Features‌

• ‌Regulatory Compliance‌

  : Meets 

  ‌USP/EP pharmacopeial standards‌

   with ≥99% HPLC purity for API manufacturing‌14.

• ‌Enhanced Stability‌

  : 36-month shelf life under controlled storage (15-25°C, dry environment)‌45.

• ‌Mechanistic Advantage‌

  : Irreversible binding to H+/K+-ATPase pumps ensures prolonged acid suppression‌23.

💊 ‌Applications‌

• ‌Pharmaceutical Formulations‌

  : Core API in 

  ‌GERD medications‌

  , 

  ‌H. pylori eradication regimens‌

  , and 

  ‌NSAID-induced ulcer prophylaxis‌

  ‌13.

• ‌Research Use‌

  : Critical for 

  ‌gastrointestinal pharmacology studies‌

   and 

  ‌acid-related disorder drug development‌

  ‌26.

📜 ‌Quality Assurance‌

• ‌Batch Traceability‌

  : Provided with COA, MSDS, and ICH-compliant impurity profiles (total impurities <0.5%)‌45.

• ‌Packaging‌

  : Available in 

  ‌1kg vacuum-sealed foil bags‌

   and 

  ‌25kg fiber drums‌

   with nitrogen protection‌56.

‌🔍 Google Keywords‌:

• Bulk USP-Grade Vonoprazan Fumarate Supplier

• TAK-438 API for GERD Treatment

• High-Purity P-CAB Inhibitor Raw Material

• Pharmaceutical-Grade Acid Reflux API‌13